Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).
Weickhardt A, Foroudi F, Lawrentschuk N, Xie J, Sidhom M, Pal A, Grimison P, Zhang A, Ng S, Tang C, Hovey E, Chen C, Hruby G, Guminski A, McJannett M, Conduit C, Tran B, Davis ID, Hayne D.
Weickhardt A, et al. Among authors: hruby g.
Eur Urol Oncol. 2023 Oct 6:S2588-9311(23)00201-8. doi: 10.1016/j.euo.2023.09.011. Online ahead of print.
Eur Urol Oncol. 2023.
PMID: 37806844